Secondary ASCVD prevention — ABFM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Increase to high-intensity statin therapy if tolerated
Patients with clinical ASCVD, including ischemic stroke, should receive high-intensity statin therapy if tolerated to reduce recurrent cardiovascular events. Additional LDL-lowering therapy may be considered based on achieved LDL and risk.
Reference: ACC/AHA Cholesterol Guideline